Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
mTOR & rapamycin
Video summary

Video description on metformin, rapamycin and semaglutide in anti-aging research

According to the description, dermatologist Dr. med. Robert Kasten explains the current study situation on metformin, rapamycin and semaglutide (Ozempic) in anti-aging research, without exaggeration; he states he does not prescribe these drugs or advise on them in his practice. [1]

Automatic summary · not editorially reviewed

The key findings

  1. The description says Dr. med. Robert Kasten, a dermatology specialist from Mainz, explains the current study situation on metformin, rapamycin and semaglutide without exaggeration. [1]

  2. The listed chapters include the epigenetic clock and what studies really show, plus a conclusion on the best anti-aging measure. [1]

  3. The description states that Dr. Kasten does not prescribe these drugs or advise on them in his practice and that the video serves scientific education only. [1]

The source at a glance

Study type / format
Video description of an educational video
Population / context
Viewers of a German-language medical education video; no study participants are described.
Summary based on
Creator description
Original publication
April 4, 2026

Three substances in the creator's anti-aging check

The description names metformin, rapamycin and semaglutide (Ozempic) as three drugs that attract attention in anti-aging research. It says Dr. med. Robert Kasten, a specialist in dermatology from Mainz, explains the current study situation understandably and without exaggeration. The listed chapters move from metformin as a former diabetes drug and longevity candidate, to rapamycin and mTOR inhibition with cellular aging, to GLP-1 agonists such as semaglutide beyond weight loss.

Supporting source [1]

Epigenetic clock chapter and stated conclusion

Two further chapters are listed: one on the epigenetic clock and what studies really show, and a conclusion on what remains the best anti-aging measure. The description does not state which studies were presented, what the epigenetic clock measured, which outcomes were compared, or what the conclusion was. It also does not report any result for metformin, rapamycin or semaglutide.

Supporting source [1]

Stated limits: no prescribing, information only

The description contains an explicit note that Dr. Kasten does not prescribe these drugs and does not advise on them in his practice, and that the video serves scientific education only. It also states that the videos and social media posts are for general information and that individual advice takes place in the private practice in Mainz. The description does not present these drugs as recommended measures.

Supporting source [1]

How to interpret this

Only the video description was available; the video and transcript were not reviewed. The description names topics and chapters but reports no study design, sample, comparator, outcome or result, so no finding can be confirmed from it.

Based on the creator’s description; the full video and transcript were not analyzed.

Source & supporting passages

[1]
Metformin, Rapamycin & Ozempic gegen das Altern: Wundermittel oder Hype? | Dr. med. Robert Kasten

okdrk: Dr. med. Robert Kasten, Dermatologe · youtube.com · April 4, 2026

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    erklärt die aktuelle Studienlage verständlich und ohne
  2. Finding 2 ↑

    Epigenetische Uhr und was Studien wirklich zeigen
  3. Finding 3 ↑

    Das Video dient ausschließlich der wissenschaftlichen Aufklärung

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…